C000078112 Holdings — Health Sciences Portfolio
All 140 reported holdings of Health Sciences Portfolio (C000078112) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Johnson & Johnson | 10.94% | $39.04M |
| Eli Lilly & Co | 10.32% | $36.81M |
| Merck & Co Inc | 5.32% | $18.97M |
| AbbVie Inc | 4.20% | $14.98M |
| Gilead Sciences Inc | 4.02% | $14.35M |
| Amgen Inc | 3.47% | $12.37M |
| UnitedHealth Group Inc | 3.05% | $10.87M |
| Pfizer Inc | 2.76% | $9.83M |
| Vertex Pharmaceuticals Inc | 2.69% | $9.59M |
| Intuitive Surgical Inc | 2.46% | $8.79M |
| Abbott Laboratories | 2.35% | $8.37M |
| Edwards Lifesciences Corp | 2.30% | $8.20M |
| Danaher Corp | 1.94% | $6.91M |
| Thermo Fisher Scientific Inc | 1.77% | $6.31M |
| Teva Pharmaceutical Industries Ltd | 1.75% | $6.24M |
| Boston Scientific Corp | 1.57% | $5.59M |
| Argenx SE | 1.50% | $5.35M |
| Stryker Corp | 1.46% | $5.22M |
| Medtronic PLC | 1.26% | $4.50M |
| AstraZeneca PLC | 1.26% | $4.48M |
| Regeneron Pharmaceuticals Inc | 1.13% | $4.05M |
| Biogen Inc | 1.12% | $3.98M |
| Bristol-Myers Squibb Co | 1.12% | $3.98M |
| Insmed Inc | 1.07% | $3.81M |
| HCA Healthcare Inc | 1.00% | $3.56M |
| Clear Street | 0.99% | $3.54M |
| Cencora Inc | 0.95% | $3.38M |
| Rhythm Pharmaceuticals Inc | 0.79% | $2.80M |
| Penumbra Inc | 0.74% | $2.63M |
| IDEXX Laboratories Inc | 0.73% | $2.59M |
| Dexcom Inc | 0.70% | $2.49M |
| Guardant Health Inc | 0.69% | $2.47M |
| Protagonist Therapeutics Inc | 0.66% | $2.34M |
| Medline Inc | 0.64% | $2.30M |
| Novartis AG | 0.64% | $2.27M |
| Waters Corp | 0.63% | $2.24M |
| Incyte Corp | 0.62% | $2.22M |
| Galderma Group AG | 0.61% | $2.19M |
| Nuvalent Inc | 0.56% | $2.00M |
| United Therapeutics Corp | 0.55% | $1.96M |
| Cogent Biosciences Inc | 0.53% | $1.91M |
| Alnylam Pharmaceuticals Inc | 0.52% | $1.86M |
| Agilent Technologies Inc | 0.51% | $1.83M |
| Revolution Medicines Inc | 0.49% | $1.75M |
| McKesson Corp | 0.49% | $1.74M |
| Moderna Inc | 0.48% | $1.70M |
| Natera Inc | 0.46% | $1.63M |
| Swib | 0.45% | $1.62M |
| CVS Health Corp | 0.44% | $1.58M |
| Elevance Health Inc | 0.44% | $1.55M |
| IQVIA Holdings Inc | 0.40% | $1.43M |
| Cooper Cos Inc/The | 0.37% | $1.32M |
| Terns Pharmaceuticals Inc | 0.33% | $1.17M |
| Illumina Inc | 0.32% | $1.13M |
| BioMarin Pharmaceutical Inc | 0.32% | $1.13M |
| Bruker Corp | 0.30% | $1.08M |
| Veeva Systems Inc | 0.30% | $1.06M |
| Summit Therapeutics Inc | 0.29% | $1.03M |
| Apogee Therapeutics Inc | 0.29% | $1.02M |
| Quest Diagnostics Inc | 0.28% | $998.13K |
| Ucb SA | 0.27% | $964.75K |
| Dianthus Therapeutics Inc | 0.26% | $929.08K |
| Bridgebio Pharma Inc | 0.26% | $923.50K |
| Stoke Therapeutics Inc | 0.26% | $921.97K |
| West Pharmaceutical Services Inc | 0.25% | $906.56K |
| Steris PLC | 0.25% | $895.80K |
| LB Pharmaceuticals Inc | 0.23% | $824.75K |
| Viking Therapeutics Inc | 0.23% | $816.01K |
| Humana Inc | 0.23% | $810.08K |
| Roivant Sciences Ltd | 0.22% | $787.79K |
| Ionis Pharmaceuticals Inc | 0.22% | $774.85K |
| Daiichi Sankyo Co Ltd | 0.21% | $749.62K |
| Cytokinetics Inc | 0.20% | $721.85K |
| Pacific Life U.S. Government Fund Direct | 0.20% | $706.72K |
| Erasca Inc | 0.19% | $694.11K |
| Agios Pharmaceuticals Inc | 0.19% | $693.24K |
| Elanco Animal Health Inc | 0.19% | $684.85K |
| Scholar Rock Holding Corp | 0.19% | $670.05K |
| Hologic Inc | 0.18% | $634.88K |
| Arcellx Inc | 0.18% | $631.74K |
| Neurocrine Biosciences Inc | 0.17% | $616.41K |
| Bio-Techne Corp | 0.17% | $615.20K |
| Viridian Therapeutics Inc | 0.17% | $612.33K |
| Exelixis Inc | 0.17% | $594.63K |
| MBX Biosciences Inc | 0.17% | $589.27K |
| Charles River Laboratories International Inc | 0.16% | $588.23K |
| Arcus Biosciences Inc | 0.16% | $585.92K |
| Glaukos Corp | 0.16% | $569.52K |
| Oruka Therapeutics Inc | 0.15% | $540.78K |
| Edgewise Therapeutics Inc | 0.14% | $483.34K |
| Eikon Therapeutics Inc | 0.13% | $456.00K |
| Bright Minds Biosciences Inc | 0.12% | $413.23K |
| Intellia Therapeutics Inc | 0.11% | $401.61K |
| Kodiak Sciences Inc | 0.11% | $385.96K |
| Alumis Inc | 0.11% | $383.56K |
| Immunome Inc | 0.11% | $375.86K |
| Palvella Therapeutics Inc | 0.11% | $374.95K |
| Novocure Ltd | 0.11% | $374.95K |
| Enanta Pharmaceuticals Inc | 0.10% | $369.59K |
| BridgeBio Oncology Therapeutics Inc | 0.10% | $363.93K |
| RadNet Inc | 0.10% | $359.32K |
| Mettler-Toledo International Inc | 0.10% | $348.09K |
| Immunocore Holdings PLC | 0.10% | $344.77K |
| Maze Therapeutics Inc | 0.09% | $324.95K |
| Monte Rosa Therapeutics Inc | 0.09% | $310.21K |
| Vaxcyte Inc | 0.09% | $304.67K |
| Dyne Therapeutics Inc | 0.08% | $302.92K |
| Alcon AG | 0.08% | $299.74K |
| Aktis Oncology Inc | 0.08% | $286.92K |
| Denali Therapeutics Inc | 0.08% | $286.60K |
| Kymera Therapeutics Inc | 0.08% | $270.28K |
| KalVista Pharmaceuticals Inc | 0.07% | $255.91K |
| CG oncology Inc | 0.07% | $244.46K |
| Beam Therapeutics Inc | 0.07% | $239.80K |
| Zealand Pharma A/S | 0.06% | $230.47K |
| BioNTech SE | 0.06% | $226.11K |
| PTC Therapeutics Inc | 0.06% | $197.71K |
| Bicara Therapeutics Inc | 0.05% | $188.74K |
| Upstream Bio Inc | 0.05% | $183.03K |
| Allogene Therapeutics Inc | 0.05% | $179.04K |
| Biohaven Ltd | 0.05% | $176.20K |
| WaVe Life Sciences Ltd | 0.04% | $147.85K |
| EyePoint Inc | 0.04% | $143.67K |
| Ocular Therapeutix Inc | 0.04% | $131.05K |
| Vor BioPharma Inc | 0.03% | $122.44K |
| REGENXBIO Inc | 0.03% | $107.76K |
| Corvus Pharmaceuticals Inc | 0.03% | $97.63K |
| Voyager Therapeutics Inc | 0.02% | $85.82K |
| Syndax Pharmaceuticals Inc | 0.02% | $80.94K |
| MoonLake Immunotherapeutics | 0.02% | $73.93K |
| 4D Molecular Therapeutics Inc | 0.02% | $71.36K |
| Nyxoah SA | 0.02% | $60.05K |
| Orchestra BioMed Holdings Inc | 0.01% | $53.18K |
| TScan Therapeutics Inc | 0.01% | $34.13K |
| Contra Abiomed, Inc. | 0.01% | $25.71K |
| Autolus Therapeutics PLC | 0.01% | $23.01K |
| Contra Blueprint Medic | 0.00% | $10.89K |
| Contra Mirati Therapeu | 0.00% | $8.55K |
| Gossamer Bio Inc | 0.00% | $7.17K |
| Contra Frequency Thera | 0.00% | $0 |
C000078112 overview: performance, fees, allocation and SEC filings